ANBOGEN THERAPEUTICS AND THE UNIVERSITY OF TOKYO ENTER COLLABORATIVE RESEARCH AGREEMENT TO EVALUATE ABT-301 ACROSS MULTIPLE TUMOR TYPES, TARGETING ACCELERATED HUMAN CLINICAL INDICATION EXPANSION

Reuters · 3d ago

Please log in to view news